Shuo Luan

Dr. Shuo Luan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
SLShuo Luan
Shuo Luan
SWShaoling Wang
Shaoling Wang
CLCaina Lin
Caina Lin
SFShengnuo Fan
Shengnuo Fan
CLCuicui Liu
Cuicui Liu
SWShaoling Wu
Shaoling Wu
Background and Objective: Osteonecrosis of the femoral head (ONFH) is a devastating disease, and there is some evidence that extracorporeal shock wave therapy (ESWT) and intra-articular platelet-rich plasma (PRP) injection might alleviate pain and improve joint function in individuals with ONFH. The objective of this study was to compare the effectiveness and safety of PRP and ESWT in symptomatic ONFH patients. Methods: A total of 60 patients aged 40– 79 with unilateral ONFH at Association Research Circulation Osseous (ARCO) stages I, II, and III were randomly assigned to the PRP (N=30) or the ESWT group (N=30). Four treatment sessions were provided in both groups. Assessments were performed at baseline, and 1-, 3-, 6-, and 12-month. Primary outcomes were measured by the visual analogue scale (VAS), and pressure pain thresholds (PPTs). Secondary outcomes were assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Harris Hip Score (HHS), and magnetic resonance imaging (MRI). The linear mixed-model analysis was used to evaluate the differences between groups and within groups and the “group by time” interaction effects. Results: There were significant differences between groups in terms of changes over time for VAS, PPTs, WOMAC, and HHS since 3-month and maintained up to 12-month (P< 0.05, except for PPTs at 12-month). The simple main effects showed that the patients in PRP group had greater improvements in VAS (mean difference = − 0.82, 95% CI [− 1.39, − 0.25], P=0.005), WOMAC (mean difference = − 4.19, 95% CI [− 7.00, − 1.37], P=0.004), and HHS (mean difference = 5.28, 95% CI [1.94, 8.62], P=0.002). No related adverse events were reported. Conclusion: This study supported the effectiveness and safety of both the PRP injection and ESWT in treating ONFH patients. For symptomatic patients with ONFH, intra-articular PRP injection appeared superior to ESWT in pain relief and functional improvement.

2 May 2022 in Stem Cells International
Verified
Journal Article
Open access
PDF file
YWYanxue Wang
Yanxue Wang
SLShuo Luan
Shuo Luan
ZYZe Yuan
Ze Yuan
SWShaoling Wang
Shaoling Wang
SFShengnuo Fan
Shengnuo Fan
SWShaoling Wu
Shaoling Wu
Glucocorticoid-induced osteonecrosis of the femoral head (ONFH) is a refractory disease. The treatment options for ONFH, especially nonsurgical ones, merit further investigation. To evaluate the combinatorial therapeutic effects of platelet-rich plasma clot releasate (PRCR) and umbilical cord mesenchymal stem cells (UC-MSCs) on glucocorticoid-induced ONFH, a dexamethasone (DEX)-treated cell model and a high-dose methylprednisolone (MPS)-treated rat model were established. Cell counting kit-8 (CCK-8) assay was performed in vitro to determine the optimum dosage of PRCR for UC-MSC viability. The effects of PRCR, UC-MSCs, and PRCR + UC-MSCs on cell viability, apoptosis, migration, and differentiation capacities of DEX-treated bone marrow mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cell (HUVECs) were explored via Transwell assays. Western blotting was conducted to evaluate the expression levels of RUNX2, VEGF, caspase-3, and Bcl-2 in the coculture systems. Ultrasound-guided intra-articular PRCR, UC-MSCs, and PRCR + UC-MSC injections were performed on the ONFH model rats. Microcomputed tomography, histological and immunohistochemical analyses, tartrate-resistant acid phosphatase (TRAP) staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were used to assess the therapeutic effects of PRCR and UC-MSCs on bone loss and necrosis induced by high-dose MPS. Results of this study revealed that the in vitro application of PRCR, UC-MSCs, and PRCR + UC-MSCs reversed the impaired proliferation and migration capacities and resisted apoptosis of BMSCs and HUVECs induced by DEX. Moreover, the PRCR and UC-MSC application significantly improved the alkaline phosphatase (ALP) and alizarin red (ALR) staining of BMSCs and tube formation capacity of HUVECs and promoted the protein expression of RUNX2 in BMSCs and VEGF in HUVECs. Similarly, in the ONFH rat model, the intra-articular injection of UC-MSCs and PRCR improved the subchondral bone mass parameters; promoted the expression of ALP, RUNX2, and VEGF; suppressed osteoclast overactivity; and resisted cell apoptosis. The combination of PRCR and UC-MSCs shows promising therapeutic effects in treating glucocorticoid-induced ONFH. The current study provides important information on intra-articular therapy, paving the way for the clinical management of ONFH in the future.

19 August 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
Qing ZhaoQing Zhao
Qing Zhao
QWQizhi Wu
Qizhi Wu
Ruoxi LaiRuoxi Lai
Ruoxi Lai
SLShuo Luan
Shuo Luan
Introduction Numerous studies have indicated that sedentary behaviour (SB) negatively impacts cognitive function, while engaging in physical activity (PA) helps maintain cognitive performance and delay cognitive decline. However, fewer studies have examined the interaction between these two factors on cognitive function, especially among the Chinese older population. In the realm of healthy and active ageing, intrinsic capacity emerges as another crucial determinant for maintaining functional wellness. However, the independent and joint relationship of SB and PA to intrinsic capacity remains unknown. Given the substantial implications of cognitive function and intrinsic capacity decline, this study will be the first to investigate the independent and joint association of SB and PA with cognition and intrinsic capacity in Chinese older adults. Methods and analysis This is a single-centre, cross-sectional, observational and exploratory study design targeting the older population from communities in Beijing. Our study population will include 270 older individuals aged 65 years and above. SB and PA levels will be tracked using triaxial accelerometers (GT3X+, ActiGraph, Pensacola, FL, USA), worn on the dominant-side waist by participants for seven consecutive days. A well-designed questionnaire will be used to gather initial data on the sociodemographic and other characteristics (all relevant risk factors for mild cognitive impairment (MCI) and intrinsic capacity decline). These characteristics will later be included as confounders in multivariate regression analyses. Participants will be screened for MCI using the montreal cognitive assessment scale, the clinical dementia rating scale and the activities of daily living scale. The amnestic MCI subtype will undergo additional evaluation using the mini-mental state examination scale and the MemTrax continuous memory recognition test. The integrated care for older people screening tool will evaluate the intrinsic capacity of older adults. To further investigate the interaction between SB and PA, participants will be divided into the following groups: (1) Mildly sedentary+active, (2) Mildly sedentary+inactive, (3) Severely sedentary+active and (4) Severely sedentary+inactive. 270 older participants will be stratified by age: 65–69 years, 70–79 years and ≥80 years. We will compare the prevalence of MCI and amnestic MCI, as well as intrinsic capacity scores, among older adults with different levels of SB and PA across these three age groups, and calculate ORs and 95% CIs. Ethics and dissemination Approval for the project was granted by the Sports Science Experiment Ethics Committee of Beijing Sport University on 12 June 2024 (ID: 2024193H). Participants will provide informed consent, guaranteeing voluntary participation. The data collected will be anonymised and securely stored in a database. The results of the study will be disseminated through open-access, peer-reviewed publications and scientific events. Trial registration number ChiCTR2400085482.

1 May 2025 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
SLShuo Luan
Shuo Luan
JSJia Song
Jia Song
BRBin Ruan
Bin Ruan
YZYuetong Zhu
Yuetong Zhu
DLDongsen Liu
Dongsen Liu
JQJinghua Qian
Jinghua Qian
Purpose: To translate and culturally adapt the Evidence-Based Practice and Evidence-Informed Practice Questionnaire into the Chinese version and evaluate its psychometric properties. Methods: The process of translation and cross-cultural adaptation adhered to the established guidelines, followed by psychometric evaluation that assessed floor/ceiling effects, face validity, content validity, construct validity, internal consistency, and test–retest reliability. The evaluation engaged 5 experts and 279 students (170 undergraduates and 109 postgraduates) from Beijing Sport University. Questionnaire items were categorized according to Evidence-Based Practice (EBP) and Evidence-Informed Practice (EIP) concepts, with varying response options for degree and frequency. Forty students completed the Chinese version of the questionnaire for the second time after a two-week period. Results: No floor or ceiling effects were observed. Following the revision of item 32 and deletion of item 14, the Item-Level Content Validity Index (I-CVI) for all other items ranged from 0.80 to 1.00, with an average scale-level CVI (S-CVI/Ave) of 0.91. The final Chinese version of the questionnaire consists of 52 items, showing adequate internal consistency, with Cronbach’s alpha values of 0.78, 0.86, 0.86, and 0.89 for the EBP (degree and frequency) and EIP (degree and frequency) items, respectively. Comparison between test–retest scores produced significant differences in all items, with Spearman correlation coefficient (r) ranging from 0.33 to 0.80 (p< 0.05), except for item 16 (r=0.29, p=0.065). Exploratory Factor Analysis (EFA) results indicated Kaiser–Meyer–Olkin (KMO) values for EBP degree, EBP frequency, and EIP degree items ranging from 0.78 to 0.87. Bartlett’s test of sphericity yielded significant results, explaining 63.62%, 69.35%, and 70.91% of the total variance, respectively, after removing items 23 and 42– 44 (cross-loading items). Conclusion: The Chinese version of the Evidence-Based Practice and Evidence-Informed Practice Questionnaire demonstrated good psychometric properties for assessing the effectiveness of EBP and EIP educational programs tailored for physiotherapy and exercise rehabilitation students.

30 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
SLShuo Luan
Shuo Luan
HLHaojie Li
Haojie Li
Qing ZhaoQing Zhao
Qing Zhao
JCJiahui Cong
Jiahui Cong
HHHanzhi He
Hanzhi He
JQJinghua Qian
Jinghua Qian
Introduction Epidemiological evidence regarding the impact of elite athletic careers on cognitive trajectories remains contentious. Although consistent physical activity has been associated with long-term brain health, former elite athletes appear to represent a unique population. While past research has established a connection between sport-related concussions (SRCs) and later cognitive decline, less attention has been given to the cognitive function of former athletes who have not experienced SRCs. Therefore, well-structured cross-sectional studies accounting for established dementia risk factors are needed to compare mild cognitive impairment (MCI) prevalence between former elite athletes and the general population. Methods and analysis This cross-sectional study will be conducted at Beijing Sport University (BSU) in Beijing, China. It is designed as a comparative study, aiming to recruit a sample of around 360 participants aged 65 and above. This sample will comprise 180 former elite athletes without a history of SRCs recruited via the BSU Retirement Welfare Office (the former athlete group), and 180 age-matched individuals from the communities in three districts in Beijing (the comparison group). Participants will complete a comprehensive questionnaire covering sociodemographic information, dementia-related risk factors, current physical activity levels and, for the former athlete group specifically, details of their athletic careers. MCI and instrumental activities of daily living will be assessed using the Montreal Cognitive Assessment, Memtrax continuous recognition test and Lawton Instrumental Activities of Daily Living (IADL) scale. The primary objective is to determine whether former elite athletes without a history of SRCs have a lower MCI prevalence than the general population. The secondary objective is to assess if these former elite athletes have a reduced prevalence of amnestic MCI and impairment in IADL compared with the general population. Additionally, the study aims to explore whether specific career-related characteristics of former athletes, such as the type of sport and contact exposure, are correlated with their cognitive function and IADL abilities in later life as a secondary exploratory component. The study will calculate the crude prevalence ratios (PRs) and adjusted prevalence ratios (aPRs) with 95% CIs using the modified Poisson regression model with robust error variance. Ethics and dissemination Ethical approval was obtained from the Ethics Committee/Internal Review Board of BSU (approval number: 2024042H). All procedures will adhere to the Helsinki Declaration. The study’s findings will be provided to participants as deemed appropriate. The outcomes will be communicated through abstract presentations at national or international conferences/academic seminars, as well as through publication in a peer-reviewed journal. Trial registration number ChiCTR2400085800.